Journal: Theranostics
Article Title: Endothelium-specific sensing of mechanical signals drives epidermal aging through coordinating retinoid metabolism
doi: 10.7150/thno.112299
Figure Lengend Snippet: Mdk-Sdc4 axis orchestrates epidermal regeneration through retinoid-mediated endothelial-basal cell crosstalk. A. FeaturePlot showing the expression changes of Rbp1 in scRNA-seq data from young and aged mouse skin. B. KEGG enrichment analysis highlighting the signaling pathways specifically enriched in Rbp1-positive cells in mouse skin. C. Upper panel: Representative immunofluorescence images showing the expression of K14 and PCNA in RP-RBP1 and control groups (left), and quantitative analysis of PCNA-positive cell numbers (right). N = 3, ****p < 0.0001. Lower panel: Representative H&E staining images showing changes in the epidermis of RP-RBP1 and control groups (left), and quantitative analysis of epidermal thickness. N = 3, ***p < 0.001. D. Violin plot showing the expression levels of Rbp1, Rara, and Rbp4 in epidermal cell clusters of skin organoids derived from neonatal and aged mice. E. Schematic diagram illustrating the reprogramming of aged mouse skin organoids using all-trans retinoic acid (atRA) and all-trans retinol (atRE). F. RT-qPCR analysis comparing the expression levels of senescence-associated markers Cdkn1a and Cdkn2a, as well as epidermal growth-related genes Egfr, Mki67, and Tp63 in control, atRA, and atRE groups, n = 3, *p < 0.05, **p < 0.01, ***p < 0.001, “ns” means no significance. G. Representative immunofluorescence images showing the expression of K14, Laminin, and P63 in control, atRA, and atRE groups. H. Quantitative analysis of the number of K14-positive cell layers, Laminin signal intensity, and P63-positive cell counts, n = 3, **p < 0.01, ***p < 0.001, “ns” means no significance.
Article Snippet: Following dorsal hair removal with electric clippers, mice received daily subcutaneous injections (50 μL/mouse) of the following agents for 7 consecutive days: Pyrintegrin (50 μM in PBS; MedChemExpress, HY-13306); SU6656 (40 μM in PBS; MedChemExpress, HY-B0789); Recombinant RBP1 protein (100 μg/mL in PBS; MedChemExpress, HY- P71093 ); MDK signaling inhibitor (20 μM in PBS; MedChemExpress, HY-110171); Three retinoid metabolites (Rol, RP, and HPR) were sourced from TargetMol and applied at a concentration of 50 μM each; Control groups received equivalent volumes of PBS vehicle.
Techniques: Expressing, Protein-Protein interactions, Immunofluorescence, Control, Staining, Derivative Assay, Quantitative RT-PCR